Crescentic glomerulonephritis is mediated by inappropriate humoral and cellular immune responses toward self-antigens that may result from defects in central and peripheral tolerance. Evidence now suggests that regulatory T cells 
Crescentic glomerulonephritis is mediated by inappropriate humoral and cellular immune responses toward self-antigens that may result from defects in central and peripheral tolerance. Evidence now suggests that regulatory T cells (Tregs) may be of pathophysiological importance in proliferative and crescentic forms of glomerulonephritis. To analyze the role of endogenous Tregs in a T celldependent glomerulonephritis model of nephrotoxic nephritis, we used 'depletion of regulatory T cell' (DEREG) mice that express the diphtheria toxin receptor under control of the FoxP3 (forkhead box P3) gene promoter. Toxin injection into these mice efficiently depleted renal and splenic FoxP3
þ Treg cells as determined by fluorescentactivated cell sorting (FACS) and immunohistochemical analyses. Treg depletion exacerbated systemic and renal interferon-c (IFNc) expression and increased recruitment of IFNc-producing Th1 cells into the kidney without an effect on the Th17 immune response. The enhanced Th1 response, following Treg cell depletion, was associated with an aggravated course of glomerulonephritis as measured by glomerular crescent formation. Thus, our results establish the functional importance of endogenous Tregs in the control of a significantly enhanced systemic and renal Th1 immune response in experimental glomerulonephritis. 2, 3 With respect to human disease, one report indicates that CD25 þ T cells emerge following acute episodes of Goodpasture's disease suppressing the response to the Goodpasture autoantigen. 4 Furthermore, the potential of Tregs to suppress the pathogenic immune responses in kidney disease has recently been proven in a model of crescentic glomerulonephritis in mice. The adoptive transfer of CD4 þ CD25 þ Tregs showed that Tregs downregulate the nephritogenic immune response directly at the systemic site of antigen-specific T-cell priming, namely the renal lymph node. 5 In consecutive studies, Eller et al. 6 demonstrated that the chemokine receptor CCR7 (chemokine (C-C motif) receptor 7) regulates the trafficking of Tregs to the lymph node in experimental glomerulonephritis, which is essential for their anti-inflammatory properties. Our group recently provided evidence that Treg cells migrate in a CCR6-CCL20-dependent manner into the inflamed kidney in crescentic glomerulonephritis and might locally suppress immunemediated renal inflammation. 7 This study was designed to examine the potential role of endogenous Tregs in crescentic glomerulonephritis. We therefore induced the T cell-dependent model of nephrotoxic nephritis (NTN) in 'depletion of regulatory T cell' (DEREG) mice that express the diphtheria toxin (DTx) receptor and green fluorescent protein (GFP) under control of the FoxP3 (forkhead box P3) promoter, allowing selective and efficient depletion of FoxP3 þ Treg cells by DTx injection. 8 Hence, we intended to address whether Treg depletion influences the clinical course of experimental glomerulonephritis, and if so, to study their potential mechanisms of action.
RESULTS

Functional involvement of endogenous Tregs in NTN
To investigate the role of endogenous Tregs, we determined the frequency of CD4 þ CD25 þ FoxP3 þ Tregs upon induction of NTN in a time course experiment. Interestingly, the number of Tregs was increased from day 5 onward, as shown by immunohistological FoxP3 staining (Figure 1a and b) .
To evaluate the immunosuppressive capacity of Tregs from nephritic mice compared with their counterparts from healthy control mice, we isolated splenic CD4 þ CD25 þ Tregs from both nephritic and healthy control mice and performed T-cell co-culture experiments. Enzyme-linked immunosorbent assay (ELISA) analysis of supernatants from co-cultures of Tregs and CD4 þ CD25 À responder T cells indicated that Tregs from nephritic mice maintained their in vitro suppressive capacity and might be even more potent than Tregs from healthy controls to inhibit the production of interleukin (IL)-2 and interferon-g (IFNg) by responder T cells (Figure 1c 
Depletion of Tregs in DEREG mice by injection of DTx
To examine the involvement of endogenous Tregs in the model of crescentic glomerulonephritis, we used C57BL/6 DEREG mice in which specific depletion of FoxP3 þ Tregs by injection of DTx and tracking of green fluorescent Tregs by fluorescent-activated cell sorting (FACS) analysis can be performed. To assess the efficiency of Treg depletion after repetitive injection of 1 mg DTx per mouse (day À1 and day 3 upon NTN induction), FoxP3 expression was quantified in spleen and kidney at 7 days after NTN induction. Indeed, frequency of CD4 þ FoxP3 þ Tregs was significantly reduced in both spleen (Figure 2a ; 7.8 vs o1%) and kidney tissue (Figure 2b ; 20.1 vs 2.6%) of DTx-treated mice in contrast to control nephritic mice as shown by intracellular FoxP3 staining with subsequent FACS analysis. GFP expression was also reduced in accordance to FoxP3 expression (data not shown). Successful renal Treg depletion was confirmed by histological staining of FoxP3 (Figure 2c ). The frequency of Tregs was significantly reduced by B80% at 4 days after the second DTx challenge (Figure 2d : FoxP3 þ Tregs (cells per low power field): 24.7±2.7 vs 5.3±1.5; **Po0.01).
Aggravated NTN in Treg-depleted nephritic mice
Next, we induced NTN in C57BL/6 wild-type (wt) and DEREG mice with and without Treg depletion. Examination of periodic acid-Schiff (PAS)-stained kidney sections in the T cell-mediated autologous phase at day 7 after injection of the nephritogenic sheep serum revealed glomerular and tubulointerstitial damage. First, PAS-positive material was deposited intraglomerularly. Moreover, formation of cellular crescents and hypercellularity account for glomerular alterations (Figure 3a ). In the tubulointerstitial compartment, aberrant leukocyte infiltration and focal destruction of the regular tissue structure were detectable indicated by tubular dilatation and intratubular protein casts (data not shown).
To quantify glomerular and tubular tissue damage, PASstained kidney sections were evaluated as previously described. 7 The frequency of glomerular crescent formation on day 7 of NTN was significantly increased in Treg-depleted DEREG mice compared with nephritic DEREG mice without DTx injection (Figure 3b (% 
Upregulation of renal IFNc response upon Treg depletion and NTN induction
To assess the renal T helper cell response on day 7 upon NTN induction, we first isolated RNA from renal cortex of nephritic DEREG and wt mice as well as the corresponding To evaluate whether the absence of Tregs during the induction phase of nephritis is sufficient for the aggravated phenotype in Treg-depleted mice, we directly compared a single injection of DTx on day -1 with the continuous Treg depletion (days -1 and 3; Supplementary Figure S1 online). Interestingly, early depletion of Tregs resulted in a sustained reduction of splenic Tregs from 16.7 to 5.9% up to day 7, whereas a double DTx injection was necessary for complete depletion of splenic Tregs (Supplementary Figure S1A online:
16.7 ± 0.75 vs 2.9 ± 0.5; ***Po0.0001). Accordingly, glomerular damage was only slightly elevated in mice with a single early depletion but was considerably aggravated in continuously depleted mice (Supplementary Figure S1B online 10 and IgG2b (Figure 6b ). 
DISCUSSION
Tregs develop in the thymus in order to regulate autoimmunity in the periphery. Upon inflammation, they become activated and increase in number, either by proliferation of thymus-derived naturally occurring natural Tregs and/or by peripheral conversion of CD4 þ CD25
þ Tregs. 11 Here we describe that upon induction of experimental crescentic glomerulonephritis, frequency as well as absolute number of 
FoxP3
þ Tregs increased substantially within renal tissue and more weakly within spleen.
Depletion of Tregs by repetitive injections of DTx on day -1 and day 3 upon NTN induction resulted in exacerbation of glomerular crescent formation and mouse anti-sheep IgG antibody production as well as in enhanced systemic and renal IFNg production. However, depletion of Tregs only during the heterologous phase of NTN nephritis, that is, when antigen-specific priming is likely to occur in the lymphoid tissue, failed to increase crescent formation (Supplementary Figure S1B online). We observed similar results by starting Treg depletion at the beginning of the autologous phase (data not shown). Hence, it seems likely that both Tregs that home in the lymphoid tissue and Tregs that migrate into the inflamed kidney control glomerulonephritis. The enhanced IFNg response observed in the aggravated phenotype correlated with an increase of macrophage/monocyte/DC and T-cell infiltration into periglomerular and interstitial areas of the renal cortex. As Tregs were depleted in this experimental setting, the infiltrating CD3 þ T cells were quantified (***Po0.0001). All analyses were performed at day 7 after induction of NTN.
T cells most likely consisted of activated effector T lymphocytes of which the CD4
þ cells indeed produced substantially increased amounts of IFNg whereas IL-17 production remained unaffected, although glomerular injury in our model is mediated by a Th1 as well as by a Th17 response. 9, 12 However, it seems noteworthy that the systemic release of IL-17 detected in supernatants of splenocyte cultures was significantly suppressed in the Treg-depleted group. In view of the fact that Tregs also suppress maturation and function of DCs, 13 this can be explained by the observation that IL-12, the major inducer of IFNg, decreases IL-17 production.
14 Intriguingly, a recent publication also showed that Tregs from patients with active pulmonary tuberculosis suppressed IFNg production, whereas the Th17 response remained unaffected. 15 Taken together, the most dramatic effect of Treg depletion observed in our study was aggravation of the IFNg T-cell response. These results suggest that the observed increase of frequency and absolute number of immunosuppressive Tregs during acute NTN regulates the systemic and local inflammatory Th1 response.
Noteworthy, in our experiments DEREG mice followed the equivalent characteristic features of NTN compared with C57BL/6 wt mice. Furthermore, DTx neither caused renal toxicity in wt or DEREG mice nor nonresponsiveness toward itself, 16 as PAS staining failed to show histopathological alterations and DTx efficiently depleted Tregs as measured 4 days after the second injection, respectively.
Up to now, three reports dealt with suppressive effects of Tregs in the planted antigen model of nephrotoxic serum nephritis. Adoptive transfer of CD4 þ CD25 þ Tregs protected mice from nephritis induced by anti-glomerular basement membrane rabbit serum. Measuring tissue levels of FoxP3 mRNA, the authors concluded that most of the adoptively transferred Tregs migrated to secondary lymphoid organs but not into the inflamed kidney. 5 However, using FACS analysis and quantitative immunohistochemistry, we could recently demonstrate that adoptively transferred Tregs migrate into the kidney as long as they express the chemokine receptor CCR6, 7 and CCR6 expression by adoptively transferred Tregs was absolutely necessary for their protective effect. Hence, together with the finding that Treg depletion only in the heterologous phase failed to induce the aggravated phenotype, it seems that CD4 þ FoxP3 þ Tregs have to accumulate within the inflamed kidney, at least in dependence of CCR6, in order to sufficiently suppress glomerulonephritis. Results of the third report suggest that lymphoid homing of Tregs is a prerequisite for downregulation of anti-glomerular basement membrane nephritis. 6 Our results presented here show that in contrast to spleen, CD4 þ FoxP3 þ Tregs substantially increased within kidney during NTN nephritis in comparison with normal frequency of B5% in healthy mice, and depletion of these cells significantly correlated with aggravation of glomerulonephritis. The necessity of inflammatory tissue-homing Tregs for suppression of inflammatory tissue damage has also been observed in models of intestinal inflammation 17 and inflammatory liver injury. 18 Taken together, these data indicate that the anti-inflammatory functions of Tregs in experimental glomerulonephritis take (chemokine (C-X-C motif) ligand 10) and T-bet was performed in nephritic DEREG mice ( ± DTx; ± aIFNg) and wt littermates (***Po0.0001, *Po0.05). The mRNA levels are expressed as x-fold of nonnephritic wt controls. (e) Circulating titers of mouse anti-sheep total immunoglobulin G (IgG) and isotypes of IgG1, IgG2a/c, and IgG2b were measured by enzyme-linked immunosorbent assay (ELISA) in wt mice and DEREG nephrotoxic nephritis (NTN) mice with or without treatment of DTx and/or aIFNg. Serum was diluted as indicated (***Po0.0001, **Po0.01, *Po0.05). All analyses were performed 7 days after NTN induction. place in the inflamed kidney itself and in the secondary lymphatic organs such as the renal lymph nodes. In addition to anti-glomerular basement membrane nephritis, 5 adoptively transferred Tregs have been shown to prevent murine lupus nephritis. 19 However, Treg cells did not only suppress 'immune-mediated' glomerulonephritis, but also 'non-immune' toxin-mediated kidney injury in the adriamycin nephropathy model. In this model, polyclonal CD4 þ CD25 þ Tregs 20 and, moreover, FoxP3-transduced T cells, 21 gd T cells, or alternatively activated macrophages 3 were approved as efficient immunotherapy against renal injury. As anti-inflammatory cytokines represent one critical mechanism of regulatory immune cells including Tregs, these findings support the concept that Tregs not only suppress adaptive T-cell responses but also pathology driven by innate immune mechanisms. 22 Hence, the immunosuppressive mechanisms by which Tregs suppress glomerulonephritis resulting from different etiologies remain to be elucidated.
In patients with autoimmune kidney disease such as lupus nephritis, decreased proportions of Tregs have been reported to inversely correlate with clinical disease activity. 23, 24 However, several studies also reported unaltered or even increased numbers of Tregs in lupus patients and positive correlation with disease activity. Similar results were obtained when the functional immunosuppressive activity of Tregs from lupus patients was assessed. These divergent results can be explained by the fact that in contrast to the murine system, in humans FoxP3 is rather an activity marker for T cells than a specific marker for Tregs. Although one can imagine that Treg numbers and function are impaired during chronic disease, our results shown here demonstrate that during acute glomerulonephritis, Treg numbers initially increased and their immunosuppressive function was at least as effective as the function of Tregs from healthy controls.
In conclusion, depletion of Tregs exacerbated acute kidney inflammation and glomerular injury, an effect that was most likely mediated by IFNg, as IFNg production by intrarenal and splenic CD4 þ T cells substantially increased and antiIFNg antibodies significantly suppressed this effect. Hence, this study might be useful to evaluate novel therapeutic approaches by modulating Tregs in order to suppress Th1 immune responses in kidney diseases.
MATERIALS AND METHODS Animals
Male DEREG mice expressing the DTx receptor and GFP under control of the FoxP3 promoter 8 and sex/age-matched (8-10 weeks old) C57BL/6 wt controls were obtained from animal facilities of the Universitätsklinikum Hamburg-Eppendorf. Animals received humane care according to guidelines of the National Institute of Health in Germany. Experiments were approved by the institutional review board 'Behörde für Soziales, Familie, Gesundheit und Verbraucherschutz' (Hamburg).
Animal treatment and functional studies Nephrotoxic serum nephritis was induced in C57BL/6 wt and DEREG mice by intraperitoneal injection of 500 ml of nephrotoxic sheep serum per mouse. Controls were injected intraperitoneally with an equal amount of nonspecific sheep IgG. To deplete Tregs in DEREG mice, DTx (1 mg per mouse) was injected intraperitoneally either twice 24 h before NTN induction and 3 days upon NTN induction or only once 24 h before NTN induction. Rat anti-mouse IFNg monoclonal antibody (XGM1.2; see Mumberg et al.
25
); 500 mg/mouse) or rat IgG was injected intraperitoneally 24 h before NTN induction. Blood samples for measurement of blood urea nitrogen and assessment of systemic antibody response were obtained at the time of killing. For urine sample collection, mice were housed in metabolic cages for 6 h. Urinary creatinine and blood urea nitrogen were measured by standard laboratory methods. Albuminuria was determined by standard ELISA analysis (mice-albumin kit; Bethyl Laboratories, Montgomery, TX).
Real-time quantitative reverse transcription-PCR analysis
Total RNA was reversely transcribed followed by quantitative reverse transcription-PCR using BIORAD CFX96 real-time system and ABsoluteQPCR SYBR mix (Fisher Scientific GmbH, Schwerte, Germany). Primer pairs were used as described previously. [7] [8] [9] Relative mRNA levels were calculated after normalization to 18S rRNA using the CFX96 Manager software (Bio-Rad Laboratories, Munich, Germany).
Morphological examinations
Light microscopy and immunohistochemistry were performed by routine procedures. Crescent formation was assessed in 30 glomeruli per mouse in a blinded fashion in PAS-stained paraffin sections. Tubulointerstitial injury was estimated by point counting in four independent areas of renal cortex per mouse in 200-fold magnification. 7 Paraffin-embedded sections (2 mm) were either stained with an antibody directed against the pan-T-cell marker CD3 (A0452; Dako, Hamburg, Germany), the Treg transcription factor FoxP3 (FJK-16s; eBioscience, San Diego, CA), the macrophage/monocyte/ DC marker F4/80 (BM8; BMA, Augst, Switzerland), and sheep or mouse IgG (Jackson ImmunoResearch Europe, Newmarket, UK). Tissue sections were developed with the Vectastain ABC-AP kit (Vector Laboratories, Burlingame, CA). For FoxP3 staining, tissue sections were incubated with a polyclonal rabbit anti-rat secondary antibody (Dako) and developed with the ZytoChemPlus (AP) Polymer Kit (Zytomed Systems, Berlin, Germany). CD3 þ cells in 20 glomerular cross-sections and F4/80 þ and CD3 þ cells in 20 tubulointerstitial high power fields ( Â 400) per kidney were counted in a blinded fashion. For quantification of FoxP3 þ Tregs, at least seven low power fields ( Â 100) were counted. Glomerular mouse IgG deposition was scored from 0 to 3 in 20 glomeruli per mouse as previously described. Antigen-specific humoral immune response Mouse anti-sheep IgG antibody titers were measured by ELISA using sera collected 7 days after induction of nephritis. 7, 9, 26 In brief, ELISA microtiter plates were coated with 100 ml sheep IgG (100 mg/ml; Sigma, St Louis, MO) in carbonate-bicarbonate buffer overnight at 4 1C. After blocking with 1% bovine serum albumin in Tris-buffered saline (Sigma), plates were incubated with serial dilutions of mouse serum for 1 h at room temperature. Bound mouse IgG was detected using peroxidase-conjugated goat anti-mouse IgG (Biozol, Eching, Germany), TMB peroxidase substrate, and absorbance readings (450 nm). Lack of crossreactivity of the secondary antibody with sheep IgG was demonstrated by omitting the primary antibody. The bound mouse immunoglobulin isotypes were detected using peroxidase-conjugated rabbit anti-mouse IgG, IgG1, IgG2a/c, and IgG2b antibodies (Zymed-Invitrogen, Karlsruhe, Germany).
Leukocyte isolation from various tissues Previously described methods for leukocyte isolation from murine kidneys were used. 7, 26 In brief, kidneys were finely minced and digested for 45 min at 37 1C with 0.4 mg/ml collagenase D (Roche, Mannheim, Germany) and 0.01 mg/ml DNAse I in Dulbecco's modied Eagle's medium (Roche) supplemented with 10% heatinactivated fetal calf serum (Invitrogen, Darmstadt, Germany). Cell suspensions were sequentially filtered through 70 and 40 mm nylon meshes and washed with Hank's balanced salt solution without Ca 2 þ and Mg 2 þ (Invitrogen). Single-cell suspensions were separated using Percoll density gradient (70 and 40%) centrifugation. Single-cell suspensions of spleens were prepared according to standard laboratory procedures. In brief, tissue was passed through 70 and 40 mm nylon meshes before erythrocyte lysis. Subsequently, cells were washed several times with Hank's balanced salt solution and resuspended in RPMI-1640 with 10% fetal calf serum. Viability of the cells was assessed by Trypan blue staining before flow cytometry.
Flow cytometry
Leukocytes were stained using a standard protocol. For T-cell differentiation, isolated cells were stained with anti-CD3 (APC; eBioscience), anti-CD4 (APC-AlexaFluor750), and anti-CD45 (PerCP; both from BD Biosciences, Franklin Lakes, NJ) upon a blocking step. Staining of intracellular IFNg and IL-17 was performed as described previously. 12 In brief, splenocytes or renal leukocytes were stimulated with phorbol 12-myristate 13-acetate (50 ng/ml; Sigma) and ionomycin (1 mg/ml; Calbiochem-Merck, Darmstadt, Germany) for 5 h. After 30 min of incubation, Brefeldin A (10 mg/ml; Sigma) was added. After several washing steps and staining of cell surface markers, cells were permeabilized using Cytofix/Cytoperm (BD Biosciences). Subsequently, intracellular staining was performed using rat anti-mouse IFNg and IL-17 antibodies (V450 or PE; BD Biosciences) and an anti-FoxP3 antibody (eBioscience). Data were recorded using BD LSRII Flow Cytometry system and BD FACSDiva software.
Isolation and culture of splenic CD4
þ CD25 þ Tregs and responder T cells Spleens were excised from C57BL/6 wt 8 days after induction of NTN, and from healthy controls and passed through 100 mm nylon meshes. Sorting procedures were carried out by MACS according to the manufacturers' instructions (MACS CD4 þ T-Cell-Isolation Kit; Miltenyi Biotec, Bergisch-Gladbach, Germany). Briefly, CD4
þ T cells were enriched using a biotinylated antibody cocktail depleting all other blood cell types and anti-biotin microbeads. CD4 þ CD25 þ T cells were isolated by positive selection using phycoerythrinlabeled anti-CD25 monoclonal antibody and anti-phycoerythrin microbeads. Purity and intracellular FoxP3 expression was controlled by flow cytometry. Next, 1 Â 10 5 wt responder T cells (CD4 þ CD25 À ) isolated from healthy mice were cultured alone or with 1 Â 10 5 CD4 þ CD25 þ Tregs from nephritic wt or healthy controls for 72 h in 96-well plates precoated with anti-CD3 monoclonal antibody (5 mg/ml; clone 145-2C11; BD Biosciences). Cytokine concentrations were measured in supernatants by ELISA.
Statistical analysis
Results are expressed as mean±s.e.m. Differences between individual experimental groups were compared by Student's t-test. In case of multiple comparisons, one-way analysis of variance with post analysis by Tukey-Kramer test was used. Experiments that did not yield enough independent data for statistical analysis due to the experimental setup were repeated at least three times.
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